1-9 of 9
Frederick F. Lang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies

Erik H.P. van Putten, Anne Kleijn, Victor W. van Beusechem, David Noske, Cor H.J. Lamers, Anna L. de Goede, Sander Idema, Daphna Hoefnagel, Jenneke J. Kloezeman, Juan Fueyo, Frederick F. Lang, Charlotte E. Teunissen, René M. Vernhout, Cathy Bakker, Winald Gerritsen, David T. Curiel, Arnold Vulto, Martine L.M. Lamfers, Clemens M.F. Dirven
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1572–1585.
https://doi.org/10.1158/1078-0432.CCR-21-3324
Published: 14 April 2022
View articletitled, Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Open the PDF for Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies in another window
Includes: Supplementary data
Journal Articles

Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial

Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, Xiaoyang Ling, Cynthia Kassab, Pinaki Banerjee, Mustafa Bdiwi, Hila Shaim, Abdullah Alsuliman, Mayra Shanley, John F. de Groot, Barbara J. O'Brien, Rebecca Harrison, Nazanin Majd, Carlos Kamiya-Matsuoka, Gregory N. Fuller, Jason T. Huse, Linda Chi, Ganesh Rao, Jeffrey S. Weinberg, Frederick F. Lang, Raymond Sawaya, Elizabeth J. Shpall, Katayoun Rezvani, Amy B. Heimberger
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3565–3577.
https://doi.org/10.1158/1078-0432.CCR-20-0176
Published: 15 July 2020
View articletitled, Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Open the PDF for Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial in another window
Includes: Supplementary data
Journal Articles

Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas

Hong Jiang, Dong Ho Shin, Teresa T. Nguyen, Juan Fueyo, Xuejun Fan, Verlene Henry, Caroline C. Carrillo, Yanhua Yi, Marta M. Alonso, Tiara L. Collier, Ying Yuan, Frederick F. Lang, Candelaria Gomez-Manzano
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6801–6814.
https://doi.org/10.1158/1078-0432.CCR-19-0405
Published: 15 November 2019
View articletitled, Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas
Open the PDF for Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas in another window
Includes: Supplementary data
Journal Articles

A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models

Pascal O. Zinn, Sanjay K. Singh, Aikaterini Kotrotsou, Islam Hassan, Ginu Thomas, Markus M. Luedi, Ahmed Elakkad, Nabil Elshafeey, Tagwa Idris, Jennifer Mosley, Joy Gumin, Gregory N. Fuller, John F. de Groot, Veera Baladandayuthapani, Erik P. Sulman, Ashok J. Kumar, Raymond Sawaya, Frederick F. Lang, David Piwnica-Worms, Rivka R. Colen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6288–6299.
https://doi.org/10.1158/1078-0432.CCR-17-3420
Published: 13 December 2018
View articletitled, A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Open the PDF for A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models in another window
Includes: Supplementary data
Journal Articles

Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas

Alessandro Canella, Alessandra M. Welker, Ji Young Yoo, Jihong Xu, Fazly S. Abas, Divya Kesanakurti, Prabakaran Nagarajan, Christine E. Beattie, Erik P. Sulman, Joseph Liu, Joy Gumin, Frederick F. Lang, Metin N. Gurcan, Balveen Kaur, Deepa Sampath, Vinay K. Puduvalli
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6215–6226.
https://doi.org/10.1158/1078-0432.CCR-16-3151
Published: 12 October 2017
View articletitled, Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
Open the PDF for Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

Jun Wei, Jason Barr, Ling-Yuan Kong, Yongtao Wang, Adam Wu, Amit K. Sharma, Joy Gumin, Verlene Henry, Howard Colman, Raymond Sawaya, Frederick F. Lang, Amy B. Heimberger
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 461–473.
https://doi.org/10.1158/1078-0432.CCR-09-1983
Published: 14 January 2010
View articletitled, Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression
Open the PDF for Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression in another window
Journal Articles

Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan

Candelaria Gomez-Manzano, Marta M. Alonso, W.K. Alfred Yung, Frank McCormick, David T. Curiel, Frederick F. Lang, Hong Jiang, B. Nebiyou Bekele, Xian Zhou, Ramon Alemany, Juan Fueyo
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (2): 556–562.
https://doi.org/10.1158/1078-0432.CCR-05-1892
Published: 20 January 2006
View articletitled, Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan
Open the PDF for Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan in another window
Journal Articles

Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents

Kalkunte S. Srivenugopal, Jiang Shou, Srinivas R. S. Mullapudi, Frederick F. Lang, Jr., Jasti S. Rao, Francis Ali-Osman
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1398–1409.
Published: 01 May 2001
View articletitled, Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents
Open the PDF for Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents in another window
Journal Articles

Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor

Cordula Petersen, Sven Petersen, Luka Milas, Frederick F. Lang, Philip J. Tofilon
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2513–2520.
Published: 01 June 2000
View articletitled, Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor
Open the PDF for Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor in another window